Suggestions
Cheairs Porter
Managing Director at Harris Williams
Cheairs Porter is a Managing Director at Harris Williams, a prominent investment banking firm. He serves as the co-head of the firm's Healthcare & Life Sciences Group.12 With extensive experience in investment banking, Porter has advised clients on various assignments throughout his career.5
Professional Background
Role at Harris Williams::
- Managing Director
- Co-head of the Healthcare & Life Sciences Group
Expertise:: Porter specializes in the healthcare and life sciences sectors, providing strategic advice and guidance to clients in these industries.1
Contact Information::
- Phone: +1 804-915-0130
- Email: cporter@harriswilliams.com1
Notable Achievements
Cheairs Porter has been involved in several significant transactions and advisory roles:
-
He advised Plano Molding Co. in its sale to Ontario Teachers' Pension Plan, demonstrating his ability to facilitate major business deals.6
-
Porter recently welcomed Sam Hendler back to Harris Williams as a managing director in the Boston office, focusing on healthcare and life sciences.4
Professional Network
Cheairs Porter is well-connected in the professional community, with over 500 connections on LinkedIn.3 His profile on the platform (username: cheairs-porter-568968) serves as a hub for his professional activities and industry insights.
Through his role at Harris Williams, Porter contributes to various industry reports and insights, particularly in areas such as medical products and devices, pharmacy IT, and healthcare revenue cycle management.12
Highlights
Members of our Healthcare & Life Sciences Group will be attending the #SIIA National Conference in Phoenix! Connect with us to discuss the latest trends and opportunities in employer tech and services. #SIIALEAD https://lnkd.in/e3W73mGD
We recently advised Irrimax on their sale to ARCHIMED, a private equity healthcare specialist with offices in Europe, North America, and Asia. A global market leader in antimicrobial wound cleansing, Irrimax develops and markets Irrisept®, the market leading solution for antimicrobial wound lavage. Infection control is one of the toughest challenges for hospitals to solve, and surgical site infections generate billions of dollars in incremental costs for the U.S. healthcare system on an annual basis. The market for high-efficacy surgical and post-surgical wound irrigation is expected to grow significantly in the medium-term as the financial burden on hospitals provides incentives to implement strict protocols to manage hospital acquired infections. We look forward to following Irrimax’s continued success. https://lnkd.in/eQT-NB6j #mergersandacquisitions
